Category Archives: Global

Pharma in Argentina: An Interview with Juan Pablo Bagó

2014 marked the 80th anniversary of Laboratorios Bagó, a market leader in Argentina and also  Latin America, with products in  in 47 countries. In this interview with Pharmaboardroom.com, Juan Pablo Bagó, general director of pharma in Argentina for the Bagó group, discusses the state of R&D in Argentina, and explains why his group is planning for a 75 percent of turnover […]
Also posted in Emerging Markets, R&D, Strategy | Tagged , , , , | Leave a comment

Indonesia “Most Promising” Emerging Market in 2015

Indonesia is expected to be the most promising market for pharma next year, thanks to its new healthcare insurance scheme Jaminan Kesehatan Nasional (JKN), according to Reenita Das, partner and senior vice president of Healthcare & Life Sciences at Frost & Sullivan.
Also posted in Emerging Markets, Op-Ed | Tagged , , , , , | Leave a comment

The Year of Living Openly: Europe and Transparency 2015

The past year has brought significant changes not only in regulatory mandates and guidances but also regarding a broader overall emphasis on coordination of information and processes. The regulators have prioritized transparency and harmonization for some time but underscored them to an even greater degree in 2014; 2015 is likely to see the trend intensify.
Also posted in compliance, Europe, Guest Blog | Tagged , , , , , , | Leave a comment

Merck CEO Outlines Next Two Years as IFPMA President, Raises Ire on IP

Merck KGaA CEO Stefan Oschmann spoke last week in New York as he accepted the two-year role as president of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the R&D industry’s global trade group based in Geneva.
Also posted in leadership, Strategy | Tagged , , , , , , , | Leave a comment

Setting Biotech Standards in India

The past decade has seen considerable growth in the Indian pharmaceutical industry. The country has emerged as a key supplier of high quality and affordable medicines not only to the developing world, but also to developed economies. The sector has recorded a compound annual growth rate (CAGR) of 13.5% over the past five years and is […]
Also posted in Biotech | Tagged , , , | Leave a comment
  • Categories

  • Meta